Advanced Search
SHI Xinli, ZHANG Shuo, DING Nana, LI Mingyuan. Clostridium novyi-NT in Cancer Therapy[J]. Cancer Research on Prevention and Treatment, 2015, 42(01): 74-77. DOI: 10.3971/j.issn.1000-8578.2015.01.018
Citation: SHI Xinli, ZHANG Shuo, DING Nana, LI Mingyuan. Clostridium novyi-NT in Cancer Therapy[J]. Cancer Research on Prevention and Treatment, 2015, 42(01): 74-77. DOI: 10.3971/j.issn.1000-8578.2015.01.018
shu

Clostridium novyi-NT in Cancer Therapy

  • 1. West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu 610041, China;2. Hebei University of Chinese Medicine, Shijiazhuang 050200, China;3. Key Laboratory of Immune Mechanism and Intervention on Serious Disease in Hebei Province,Hebei Medical University, Shijiazhuang 050017, China

More Information
  • Received Date: May 04, 2014
  • Revised Date: September 08, 2014
    Graphical Abstract
    • Abstract
  • Combination bacteriolytic therapy (COBALT) has the potential in cancer therapy. Today, anaerobic bacterium Clostridium novyi-NT enrolled as anticancer agent with the current chemoradiotherapy drug are in the clinical testing stage I. In this paper, we summarize the criteria of an ideal anticancer bacterium and the oncolytic mechanism of C. novyi-NT .
    • FullText(HTML)
    • References (31)
  • [1]
    Parker RC, Plummer HC, Siebenmann CO, et al. Effect of histolyticus infection and toxin on transplantable mouse tumors[J]. Proc Soc Exp Biol Med, 1947, 66(2): 461-7.
    [2]
    Dang LH, Bettegowda C, Huso DL, et al. Combination bacteriolytic therapy for the treatment of experimental tumors[J]. Proc Natl Acad Sci U S A, 2001, 98(26): 15155-60.
    [3]
    Bettegowda C, Dang LH, Abrams R, et al. Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria[J]. Proc Natl Acad Sci U S A, 2003, 100(25): 15083-8.
    [4]
    Dang LH, Bettegowda C, Agrawal N, et al. Targeting vascular and avascular compartments of tumors with C. novyi-NT and antimicrotubule agents[J]. Cancer Biol Ther, 2004, 3(3): 326-37.
    [5]
    Agrawal N, Bettegowda C, Cheong I, et al. Bacteriolytic therapy can generate a potent immune response against experimental tumors[J]. Proc Natl Acad Sci U S A, 2004, 101(42): 15172-7.
    [6]
    Smith AB 3rd, Freeze BS, LaMarche MJ, et al. Discodermolide analogues as the chemical component of combination bacteriolytic therapy[J]. Bioorg Med Chem Lett, 2005, 15(15): 3623-6.
    [7]
    Cheong I, Huang X, Bettegowda C, et al. A bacterial protein enhances the release and efficacy of liposomal cancer drugs[J]. Science, 2006, 314(5803): 1308-11.
    [8]
    Maletzki C, Gock M, Klier U, et al. Bacteriolytic therapy of experimental pancreatic carcinoma[J]. World J Gastroenterol, 20 10,16(28): 3546-52.
    [9]
    Forbes NS. Engineering the perfect (bacterial) cancer therapy[J]. Nat Rev Cancer, 2010, 10(11): 785-94.
    [10]
    Jain RK, Forbes NS. Can engineered bacteria help control cancer?[J]. Proc Natl Acad Sci U S A, 2001, 98(26): 14748-50.
    [11]
    Nishida S, Nakagawara G. Isolation of toxigenic strains of Clostridium novyi from soil[J]. J Bacteriol, 1964, 88: 1636-40.
    [12]
    Loesche WJ. Oxygen sensitivity of various anaerobic bacteria[J]. Appl Microbiol, 1969, 18(5): 723-7.
    [13]
    Taguchi R, Ikezawa H. Hydrolytic action of phospholipases on bacterial membranes[J]. J Biochem, 1977, 82(5): 1225-30.
    [14]
    Bentley S, Sebaihia M. Bacterial therapeutics[J]. Nat Rev Microbiol, 2007, 5(3): 170-1.
    [15]
    Bettegowda C, Huang X, Lin J, et al.The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT[J]. Nat Biotechnol, 2006, 24(12): 1573-80.
    [16]
    Ball DW, Van Tassell RL, Roberts MD, et al. Purification and characterization of alpha-toxin produced by Clostridium novyi type A[J]. Infect Immun, 1993, 61(7): 2912-8.
    [17]
    Müller H, von Eichel-Streiber C, Habermann E. Morphological changes of cultured endothelial cells after microinjection of toxins that act on the cytoskeleton[J]. Infect Immun, 1992, 60(7): 30 07-10.
    [18]
    Oksche A, Nakov R, Habermann E. Morphological and biochemical study of cytoskeletal changes in cultured cells after extracellular application of Clostridium novyi alpha-toxin[J]. Infect Immun, 1992, 60(7): 3002-6.
    [19]
    Guttenberg G, Papatheodorou P, Genisyuerek S, et al. Inositol hexakisphosphate-dependent processing of Clostridium sordellii lethal toxin and Clostridium novyi α-toxin[J]. J Biol Chem, 2011, 28 6(17): 14779-86.
    [20]
    Bette P, Mauler F, Mohr C, et al. Microinjection of alpha-toxin from Clostridium novyi type A promotes meiotic maturation in Xenopus laevis oocytes[J]. Toxicon, 1990, 28(11): 1368-71.
    [21]
    Schallehn G, Eklund M, Brandis H. Phage conversion of clostridium novyi type A[J]. Zentralbl Bakteriol A, 1980, 247(1): 95 -100.
    [22]
    Eklund MW, Poysky FT, Meyers JA, et al. Interspecies conversion of Clostridium botulinum type C to Clostridium novyi type A by bacteriophage[J]. Science, 1974, 186(4162):456-8.
    [23]
    Dunn JK, Farrow CS, Doige CE. Disseminated osteomyelitis caused by Clostridium novyi in a cat[J]. Can Vet J, 1983, 24(10): 31 2-5.
    [24]
    Vleminckx WG, Diltoer MW, Spapen HD, et al. Splenic abscess with Clostridium novyi bacteraemia and sepsis[J]. Eur J Gastroenterol Hepatol, 1997, 9(3): 303-5.
    [25]
    Majumdar S, Woodcock S, Cheesbrough J. Severe sepsis following wound infection by an unusual organism-Clostridium novyi[J]. Int J Clin Pract, 2004, 58(9): 892-3.
    [26]
    Finn SP, Leen E, English L, et al. Autopsy findings in an outbreak of severe systemic illness in heroin users following injection site inflammation: an effect of Clostridium novyi exotoxin?[J]. Arch Pathol Lab Med, 2003, 127(11): 1465-70.
    [27]
    Palmateer NE, Hope VD, Roy K, et al. Infections with sporeforming bacteria in persons who inject drugs, 2000-2009[J]. Emerg Infect Dis, 2013, 19(1): 29-34.
    [28]
    Diaz LA Jr, Cheong I, Foss CA, et al. Pharmacologic and toxicologic evaluation of C. novyi-NT spores[J]. Toxicol Sci, 20 05, 88(2): 562-75.
    [29]
    Krick EL, Sorenmo KU, Rankin SC, et al. Evaluation of Clostridium novyi-NT spores in dogs with naturally occurring tumors[J]. Am J Vet Res, 2012, 73(1):112-8.
    [30]
    Agrawal N, Bettegowda C, Cheong I, et al. Bacteriolytic therapy can generate a potent immune response against experimental tumors[J]. Proc Natl Acad Sci U S A, 2004, 101(42): 15172-7.
    [31]
    Plomp M, McCaffery JM, Cheong I, et al. Spore coat architecture of Clostridium novyi NT spores[J]. J Bacteriol, 2007, 189(17): 64 57-68.
    • Related Articles

  • Related Articles

    [1]ZHANG Lin, HOU Yanhong, WU Kai, ZHANG Jing. Experimental Study on Treatment of Gastric Cancer with New Recombinant Oncolytic Vaccinia Virus Infection Combined with Immune Effective Cells and Immune Checkpoint Blocking[J]. Cancer Research on Prevention and Treatment, 2024, 51(6): 426-431. DOI: 10.3971/j.issn.1000-8578.2024.23.1380
    [2]ZHANG Ju, DONG Qiang, SHI Yongquan. Research Progress on Association Between Oral Bacteria and Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2024, 51(2): 147-151. DOI: 10.3971/j.issn.1000-8578.2024.23.0850
    [3]WANG Weichuan, CHEN Lulu, QUAN Xianglan, LI Ying, JIN Yongmin, JIN Wenbiao, YU Kexin, ZHANG Songnan. Oncolytic Adenovirus RCA-TERT-Ad35 Carrying Human Telomerase Reverse Transcriptase Promoter Targets Breast Cancer Stem Cells[J]. Cancer Research on Prevention and Treatment, 2019, 46(11): 971-976. DOI: 10.3971/j.issn.1000-8578.2019.18.1987
    [4]YANG Wei, MA Yongning, HAO Yi. Current Application of Two-Dimensional Nanomaterials Combined with Ultrasoundrelated Biomedical Technology in Cancer Therapy and Diagnosis[J]. Cancer Research on Prevention and Treatment, 2019, 46(6): 561-566. DOI: 10.3971/j.issn.1000-8578.2019.18.1625
    [5]ZHANG Yanli, ZHU Shunqin, LIU Yaling, CUI Hongjuan. 恶性黑色素瘤内科治疗研究进展[J]. Cancer Research on Prevention and Treatment, 2014, 41(01): 74-78. DOI: 10.3971/j.issn.1000-8578.2014.01.017
    [6]Zhang Ming, Lin Qiang, Shi Jinling, Zhao Jing, Yan Xiaolu. Effect of Oncolytic Adenoviruses Ad-MK Combined with Irradiation on Bladder Cancer[J]. Cancer Research on Prevention and Treatment, 2012, 39(11): 1317-1320. DOI: 10.3971/j.issn.1000-8578.2012.11.009
    [7]LIU Yan-hua, ZHENG Jun-nian, MAO Li-jun, SUN Fang-hao, WEN Ru-min, ZHANG Bao-fu, LI Wang, LIU Jun-jie, PEI Dong-sheng. Inhibitory Effects of Oncolytic Adenovirus with hTERT Small Interference RNA on Proliferation of Human Cervical Cancer HeLa Cells[J]. Cancer Research on Prevention and Treatment, 2009, 36(10): 811-814. DOI: 10.3971/j.issn.1000-8578.2009.10.001
    [10]KE Yu-hua, ZENG Hong-mei. The analysis of curative effects of CTP and NT regimen in adcanced breast cancer[J]. Cancer Research on Prevention and Treatment, 2002, 29(03): 230-232. DOI: 10.3971/j.issn.1000-8578.2208

Catalog

    Get Citation
    PDF
    XML
    Article views (1680) PDF downloads (1067) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Contact Us

    Address：116 Zhuodaoquan South Road,
    Hongshan District, Wuhan（430079）

    Tel：027－87670126

    Email：zlfzyjzz@vip.163.com

    This work is licensed under a Creative Commons Attribution 3.0 License.

    Email Alert RSS
    Total visits：16947338 Visits today：2445

    Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return